A trial of autologous T cells redirected to a specific mutation in glioblastoma patients illustrates mechanisms of resistance.
No takes yet. Share an insight, caveat, or question.
O’Rourke et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: